Johnson & Johnson is spending more than $16 billion to move deeper into treating heart disease and continue a shift started last year away from its consumer health roots.
Nov 1, 2022
0
14
Danish drugmaker Bavarian Nordic, the lone laboratory manufacturing a licensed vaccine against monkeypox, announced Tuesday a revised supply deal with Canada worth up to $470 million.
Sep 20, 2022
0
0
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
Aug 7, 2022
0
4
A deal has been reached to allow for distribution of a low-cost generic version of a long-term preventative treatment against HIV in low-income countries where most of the world's infections occur, Unitaid and the Medicines ...
Jul 28, 2022
0
12
Israeli generic drug maker Teva has reached an agreement in principle to pay $4.25 billion over 13 years to settle a series of court cases over its role in the US opioid epidemic.
Jul 27, 2022
0
2
Moderna and the UK government on Wednesday announced a deal for the US biotech firm to build a cutting-edge centre to develop and produce mRNA vaccines for respiratory diseases, including COVID.
Jun 22, 2022
0
2
The US Justice Department has challenged a plan that would dissolve Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the country's opioid crisis, while shielding its founders from lawsuits.
Sep 16, 2021
0
25
Australians love to eat out, especially fast food. About a third of household food budgets are spent on food prepared outside the home, with most of us consuming it on average two or three times a week.
Jul 13, 2021
0
1
Germany-based MorphoSys AG said Wednesday that it is buying U.S. rival Constellation Pharmaceuticals Inc. in a deal valuing the biotech company at $1.7 billion.
Jun 2, 2021
0
0
Britain's competition watchdog on Tuesday said it was investigating the planned purchase of US biotech company Alexion by COVID vaccine-maker AstraZeneca in a deal worth $39 billion.
May 25, 2021
0
1
